© 1999 by Oxford University Press
Journal of the National Cancer Institute, Vol. 91, No. 13, 1125-1130,
July 7, 1999
© 1999 Oxford University Press
Inherited Susceptibility to Bleomycin-Induced Chromatid Breaks in Cultured Peripheral Blood Lymphocytes
Affiliations of authors:J. Cloos, E. J .C. Nieuwenhuis,M. L .T. van der Sterre, G. B. Snow, B. J. M. Braakhuis, Department of Otolaryngology/Head and Neck Surgery, University Hospital Vrije Universiteit, Amsterdam, The Netherlands; D. I. Boomsma (Department of Biological Psychology), D. J. Kuik (Department of Epidemiology and Biostatistics), F. Arwert (Department of Human Genetics), University Vrije Universiteit, Amsterdam, The Netherlands.
Correspondence to: Boudewijn J. M. Braakhuis, Ph.D., Department of Otolaryngology/Head and Neck Surgery, University Hospital Vrije Universiteit, P. O. Box 7057, 1007 MB, Amsterdam, The Netherlands (e-mail: BJM.Braakhuis{at}AZVU.nl).
BACKGROUND: Susceptibility to bleomycin-induced chromatid breaks in cultured peripheral blood lymphocytes may reflect the way a person deals with carcinogenic challenges. This susceptibility (also referred to as mutagen sensitivity) has been found to be increased in patients with environmentally related cancers, including cancers of the head and neck, lung, and colon, and, in combination with carcinogenic exposure, this susceptibility can greatly influence cancer risk. The purpose of this study was to assess the heritability of mutagen sensitivity. METHODS: Heritability was determined by use of a maximum likelihood method that employed the FISHER package of pedigree analysis. Bleomycin-induced breaks per cell values for 135 healthy volunteers without cancer were determined. These individuals were from 53 different pedigrees and included 25 monozygotic twin pairs (n = 50), 14 pairs of dizygotes (twin pairs and siblings, n = 28), and 14 families selected on the basis of a first-degree relative who was successfully treated for head and neck cancer and who had no sign of recurrence for at least 1 year. All data were analyzed simultaneously, and different models of familial resemblance were fitted to the data. All P values are two-sided. Results: Our results showed no evidence for the influence of a shared family environment on bleomycin-induced chromatid breaks. Genetic influences, however, were statistically significant (P = .036) and accounted for 75% of the total variance. CONCLUSIONS: The high heritability estimate of the susceptibility to bleomycin-induced chromatid breaks indicates a clear genetic basis. The findings of this study support the notion that a common genetic susceptibility to DNA damage—and thereby a susceptibility to cancer—may exist in the general population.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  D. J. Waters, S. Shen, H. Xu, S. S. Kengeri, D. M. Cooley, E. C. Chiang, Y. Chen, D. Schlittler, C. Oteham, G. F. Combs Jr., et al. Noninvasive Prediction of Prostatic DNA Damage by Oxidative Stress Challenge of Peripheral Blood Lymphocytes Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1906 - 1910. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Wu, J. Gu, and M. R. Spitz Mutagen Sensitivity: A Genetic Predisposition Factor for Cancer Cancer Res., April 15, 2007; 67(8): 3493 - 3495. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L. Chao, C. C. Maley, X. Wu, D. C. Farrow, P. C. Galipeau, C. A. Sanchez, T. G. Paulson, P. S. Rabinovitch, B. J. Reid, M. R. Spitz, et al. Mutagen Sensitivity and Neoplastic Progression in Patients with Barrett's Esophagus: A Prospective Analysis. Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1935 - 1940. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Wu, M. R. Spitz, C. I. Amos, J. Lin, L. Shao, J. Gu, M. de Andrade, N. L. Benowitz, P. G. Shields, and G. E. Swan Mutagen sensitivity has high heritability: evidence from a twin study. Cancer Res., June 15, 2006; 66(12): 5993 - 5996. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. G. Natarajan, N. Ganesan, P. Carter-Nolan, C. A. Tucker, P. G. Shields, and L. L. Adams-Campbell {gamma}-Radiation-Induced Chromosomal Mutagen Sensitivity Is Associated with Breast Cancer Risk in African-American Women: Caffeine Modulates the Outcome of Mutagen Sensitivity Assay. Cancer Epidemiol. Biomarkers Prev., March 1, 2006; 15(3): 437 - 442. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. H.C. Dirksen, J. Cloos, B. J.M. Braakhuis, R. H. Brakenhoff, A. J.R. Heck, and M. Slijper Human Lymphoblastoid Proteome Analysis Reveals a Role for the Inhibitor of Acetyltransferases Complex in DNA Double-Strand Break Response Cancer Res., February 1, 2006; 66(3): 1473 - 1480. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Cloos, W. P.H. de Boer, M. H.J. Snel, P. van den IJssel, B. Ylstra, C. R. Leemans, R. H. Brakenhoff, and B. J.M. Braakhuis Microarray Analysis of Bleomycin-Exposed Lymphoblastoid Cells for Identifying Cancer Susceptibility Genes Mol. Cancer Res., February 1, 2006; 4(2): 71 - 77. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L.-E Wang, P. Xiong, S. S. Strom, L. H. Goldberg, J. E. Lee, M. I. Ross, P. F. Mansfield, J. E. Gershenwald, V. G. Prieto, J. N. Cormier, et al. In Vitro Sensitivity to Ultraviolet B Light and Skin Cancer Risk: A Case-Control Analysis J Natl Cancer Inst, December 21, 2005; 97(24): 1822 - 1831. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kyoizumi, Y. Kusunoki, T. Hayashi, M. Hakoda, J. B. Cologne, and K. Nakachi Individual Variation of Somatic Gene Mutability in Relation to Cancer Susceptibility: Prospective Study on Erythrocyte Glycophorin A Gene Mutations of Atomic Bomb Survivors Cancer Res., June 15, 2005; 65(12): 5462 - 5469. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Dolan, K. G. Newbold, R. Nagasubramanian, X. Wu, M. J. Ratain, E. H. Cook Jr., and J. A. Badner Heritability and Linkage Analysis of Sensitivity to Cisplatin-Induced Cytotoxicity Cancer Res., June 15, 2004; 64(12): 4353 - 4356. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. W. Mohrenweiser Genetic Variation and Exposure Related Risk Estimation: Will Toxicology Enter a New Era? DNA Repair and Cancer as a Paradigm Toxicol Pathol, January 1, 2004; 32(1_suppl): 136 - 145. [Abstract] [PDF]
|
|
|
|
 |
|
 G. Szekely, E. Remenar, M. Kasler, and S. Gundy Does the bleomycin sensitivity assay express cancer phenotype? Mutagenesis, January 1, 2003; 18(1): 59 - 63. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. W. Mohrenweiser, T. Xi, J. Vazquez-Matias, and I. M. Jones Identification of 127Amino Acid Substitution Variants in Screening 37 DNA Repair Genes in Humans Cancer Epidemiol. Biomarkers Prev., October 1, 2002; 11(10): 1054 - 1064. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Tuimala, G. Szekely, S. Gundy, A. Hirvonen, and H. Norppa Genetic polymorphisms of DNA repair and xenobiotic-metabolizing enzymes: role in mutagen sensitivity Carcinogenesis, June 1, 2002; 23(6): 1003 - 1008. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Brennan Gene-environment interaction and aetiology of cancer: what does it mean and how can we measure it? Carcinogenesis, March 1, 2002; 23(3): 381 - 387. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L Shao, M Lai, and Q Huang Mutagen sensitivity and p53 expression in colorectal cancer in China Postgrad. Med. J., November 1, 2001; 77(913): 713 - 716. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Schmezer, N. Rajaee-Behbahani, A. Risch, S. Thiel, W. Rittgen, P. Drings, H. Dienemann, K. W. Kayser, V. Schulz, and H. Bartsch Rapid screening assay for mutagen sensitivity and DNA repair capacity in human peripheral blood lymphocytes Mutagenesis, January 1, 2001; 16(1): 25 - 30. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Z. Hadi, M. A. Coleman, K. Fidelis, H. W. Mohrenweiser, and D. M. Wilson III Functional characterization of Ape1 variants identified in the human population Nucleic Acids Res., October 15, 2000; 28(20): 3871 - 3879. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z.-F. Zhang, H. Morgenstern, M. R. Spitz, D. P. Tashkin, G.-P. Yu, T. C. Hsu, and S. P. Schantz Environmental Tobacco Smoking, Mutagen Sensitivity, and Head and Neck Squamous Cell Carcinoma Cancer Epidemiol. Biomarkers Prev., October 1, 2000; 9(10): 1043 - 1049. [Abstract] [Full Text]
|
|
|
|
|
|
J. Cloos, C. R. Leemans, M. L. T. van der Sterre, D. J. Kuik, G. B. Snow, and B. J. M. Braakhuis Mutagen Sensitivity as a Biomarker for Second Primary Tumors after Head and Neck Squamous Cell Carcinoma Cancer Epidemiol. Biomarkers Prev., July 1, 2000; 9(7): 713 - 717. [Abstract] [Full Text]
|
|
|
|
|
|
S. P. Schantz, Q. Huang, K. Shah, V.V.V.S. Murty, T.C. Hsu, G. Yu, P. E. Andersen, A. G. Huvos, and R. S.K. Chaganti Mutagen sensitivity and environmental exposures as contributing causes of chromosome 3p losses in head and neck cancers Carcinogenesis, June 1, 2000; 21(6): 1239 - 1246. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z.-F. Zhang, H. Morgenstern, M. R. Spitz, D. P. Tashkin, G.-P. Yu, J. R. Marshall, T. C. Hsu, and S. P. Schantz Marijuana Use and Increased Risk of Squamous Cell Carcinoma of the Head and Neck Cancer Epidemiol. Biomarkers Prev., December 1, 1999; 8(12): 1071 - 1078. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. I. Koukourakis, C. S. Flordellis, A. Giatromanolaki, S. Koukouraki, A. Kapsoritakis, S. Potamianos, G. Retalis, E. Sivridis, B. Salsaa, A. L. Harris, et al. Oral Administration of Recombinant Human Granulocyte Macrophage Colony-stimulating Factor in the Management of Radiotherapy-induced Esophagitis Clin. Cancer Res., December 1, 1999; 5(12): 3970 - 3976. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Caporaso Genetics of Smoking-Related Cancer and Mutagen Sensitivity J Natl Cancer Inst, July 7, 1999; 91(13): 1097 - 1098. [Full Text] [PDF]
|
|